A vaccine to protect against novel H1N1 influenza is expected to be available this fall. CDC's Advisory Committee on Immunization Practices has made recommendations for a voluntary novel H1N1 vaccination effort to counter a possibly severe upcoming flu season. Various clinical trials have begun, some under the direction of the National Institutes of Health and others by manufacturers under contract with Health and Human Services.
H1N1 vaccine is still being tested in several locations across the United States and will most likely be distributed to various clinics and institutions via the state health departments. Currently the prediction for earliest release of this vaccine is late October/early November. The H1N1 vaccination process includes two injections given approximately 3 weeks apart. Health Services has boosted its supply of seasonal flu vaccine and has also requested the maximum amount of the H1N1 vaccine possible once it's available.
More information on the H1N1 Vaccine can be found by clicking here.